• Alchemy Labs posted Q2 revenue of CAD 581,027, up 16.9% year over year.
• Gross margin swung to 38.7% from -0.2%, lifting gross profit to CAD 224,803 from a gross loss.
• Operating loss widened to CAD 1.19 million, net loss widened to CAD 1.57 million, or CAD 0.06 a share.
• ExoShield revenue rose 2.5% to CAD 509,195; Crypsis generated CAD 71,382 following initial defence contribution.
• Cash was CAD 1.26 million; completed a CAD 13.74 million IPO on July 9 through 13,738,447 units at CAD 1.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alchemy Labs Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608191756NEWSFILECNPR____20260819_310527_1) on August 19, 2026, and is solely responsible for the information contained therein.